Implementation of the 2018 Human Epidermal Growth Factor Receptor 2 Guideline by American Society of Clinical Oncology/College of American Pathologists Will Reduce False-Positive Tests

被引:4
|
作者
Martin, Vittoria [1 ]
Valera, Alexandra [1 ]
De Joffrey, Melissa [1 ]
Banfi, Sara [1 ]
Mazzucchelli, Luca [1 ]
机构
[1] Inst Pathol, Locarno, Switzerland
关键词
IN-SITU HYBRIDIZATION; RECOMMENDATIONS;
D O I
10.5858/arpa.2018-0904-LE
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:411 / 412
页数:2
相关论文
共 50 条
  • [21] 2013 Update of the American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing: Impact on Immunohistochemistry-Negative Breast Cancers Reply
    Wolff, Antonio C.
    Hammond, M. Elizabeth H.
    Hicks, David G.
    Dowsett, Mitch
    Hayes, Daniel F.
    McShane, Lisa M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) : 1857 - 1859
  • [22] American Society of Clinical Oncology-College of American Pathologists Guideline Update
    Wolff, Antonio C.
    Somerfield, Mark R.
    Dowsett, Mitchell
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Mcshane, Lisa M.
    Saphner, Thomas J.
    Spears, Patricia A.
    Allison, Kimberly H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (09) : 993 - 1000
  • [23] Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer
    Lim, Tse Hui
    Lim, Alvin Soon Tiong
    Thike, Aye Aye
    Tien, Sim Leng
    Tan, Puay Hoon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (02) : 140 - 147
  • [24] Laboratory Compliance With the American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Guidelines A 3-Year Comparison of Validation Procedures
    Dyhdalo, Kathryn S.
    Fitzgibbons, Patrick L.
    Goldsmith, Jeffery D.
    Souers, Rhona J.
    Nakhleh, Raouf E.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (07) : 876 - 884
  • [25] Estrogen and Progesterone Receptor Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Guideline Update
    Allison, Kimberly H.
    Hammond, M. Elizabeth H.
    Dowsett, Mitchell
    McKernin, Shannon E.
    Carey, Lisa A.
    Fitzgibbons, Patrick L.
    Hayes, Daniel F.
    Lakhani, Sunil R.
    Chavez-MacGregor, Mariana
    Perlmutter, Jane
    Perou, Charles M.
    Regan, Meredith M.
    Rimm, David L.
    Symmans, W. Fraser
    Torlakovic, Emina E.
    Varella, Leticia
    Viale, Giuseppe
    Weisberg, Tracey F.
    McShane, Lisa M.
    Wolff, Antonio C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (05) : 545 - 563
  • [26] Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update
    Wolff, Antonio C.
    Somerfield, Mark R.
    Dowsett, Mitchell
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    McShane, Lisa M.
    Saphner, Thomas J.
    Spears, Patricia A.
    Allison, Kimberly H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3867 - +
  • [27] Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
    Giordano, Sharon H.
    Temin, Sarah
    Kirshner, Jeffrey J.
    Chandarlapaty, Sarat
    Crews, Jennie R.
    Davidson, Nancy E.
    Esteva, Francisco J.
    Gonzalez-Angulo, Ana M.
    Krop, Ian
    Levinson, Jennifer
    Lin, Nancy U.
    Modi, Shanu
    Patt, Debra A.
    Perez, Edith A.
    Perlmutter, Jane
    Ramakrishna, Naren
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2078 - U148
  • [28] National Guidelines and Level of Evidence: Comments on Some of the New Recommendations in the American Society of Clinical Oncology and the College of American Pathologists Human Epidermal Growth Factor Receptor 2 Guidelines for Breast Cancer
    Rakha, Emad A.
    Pigera, Marian
    Shaaban, Abeer
    Shin, Sandra J.
    D'Alfonso, Timothy
    Ellis, Ian O.
    Lee, Andrew H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11)
  • [29] Reappraisal of Human Epidermal Growth Factor Receptor 2 (HER2) in High-grade Urothelial Carcinoma (HGUCa) Based on American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Clinical Practice Guidelines, 2018
    Mohanty, Sambit
    Tiwari, Ankit
    Baisakh, Manas
    Naik, Subhasini
    Chawla, Preeti
    Das, Subodh
    Pradhan, Manas
    Satapathy, Kali
    Dhillon, Jasreman
    MODERN PATHOLOGY, 2019, 32
  • [30] Reappraisal of Human Epidermal Growth Factor Receptor 2 (HER2) in High-grade Urothelial Carcinoma (HGUCa) Based on American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Clinical Practice Guidelines, 2018
    Mohanty, Sambit
    Tiwari, Ankit
    Baisakh, Manas
    Naik, Subhasini
    Chawla, Preeti
    Das, Subodh
    Pradhan, Manas
    Satapathy, Kali
    Dhillon, Jasreman
    LABORATORY INVESTIGATION, 2019, 99